RADA-PHARMA International

Rada-Pharma International is a pharmaceutical company specializing in the development and commercialization of photodynamic therapy (PDT) technologies. The company's flagship product, Radachlorin, is a second-generation photosensitizer derived from chlorophyll a, used for the treatment of various malignancies and non-oncological conditions. Rada-Pharma's portfolio includes drug formulations, laser equipment, and diagnostic tools designed to provide integrated PDT solutions. Their research extends into oncology, dermatology, and ophthalmology, with a focus on minimally invasive treatments that minimize side effects. The company operates primarily out of Russia but has established international partnerships for clinical research and distribution.